Cargando…

The Assessment of Disease Activity in Rheumatic Diseases

Detalles Bibliográficos
Autores principales:	Arayssi, Thurayya, Touma, Zahi, Nikpour, Mandana, Ghandour, Lilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838830/ https://www.ncbi.nlm.nih.gov/pubmed/24307902 http://dx.doi.org/10.1155/2013/275691

Ejemplares similares

Cross-cultural adaptation and validation of Behçet's disease quality of life questionnaire
por: Touma, Zahi, et al.
Publicado: (2011)

Remediation of learners struggling with communication skills: a systematic review
por: Al-Sheikhly, Deema, et al.
Publicado: (2020)

The potential role of 'non-rheumatic’ therapies in rheumatic disease
por: Massarotti, Elena M, et al.
Publicado: (2013)

Autoimmune Rheumatic Diseases
por: Anaya, Juan-Manuel, et al.
Publicado: (2014)

Spine and Rheumatic Diseases
por: Wei, James Cheng-Chung, et al.
Publicado: (2015)

Neuroimaging in rheumatic diseases
por: Santos, Alair Sarmet
Publicado: (2018)

Microangiopathy in Rheumatic Diseases
por: Lambova, Sevdalina Nikolova
Publicado: (2023)

Bibliometric analysis of rheumatology research in the Arab countries
por: Bayoumy, Karim, et al.
Publicado: (2016)

The role of stress in rheumatic diseases
por: Hassett, Afton L, et al.
Publicado: (2010)

Vaccinations in rheumatic diseases
por: Szwejkowska, Martyna, et al.
Publicado: (2020)

Polygenic risk scores and rheumatic diseases
por: Brown, Matthew A., et al.
Publicado: (2021)

Gout: will the “King of Diseases” be the first rheumatic disease to be cured?
por: Singh, Jasvinder A.
Publicado: (2016)

Perceptions of patients with rheumatoid arthritis about self-assessment of disease activity after watching an educational video: a qualitative pilot study from the AUTO-DAS in Middle Eastern Arab countries project
por: Ziadé, Nelly, et al.
Publicado: (2021)

Comorbidities and multimorbidity in rheumatic diseases
por: Filipowicz-Sosnowska, Anna
Publicado: (2019)

Assessment of Evidence for COVID-19 and Rheumatic Diseases: Brief Considerations about Immunity and Pathophysiology
por: Jadali, Zohreh
Publicado: (2021)

Predictors of mortality in chronic rheumatic heart disease
por: Talwar, K. K., et al.
Publicado: (2016)

Comparing the prevalence of rheumatic diseases in China with the rest of the world
por: Felson, David T
Publicado: (2008)

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
por: Nakken, Britt, et al.
Publicado: (2012)

Signal Transduction Pathways in Chronic Inflammatory Rheumatic Diseases
por: Cope, Andrew P
Publicado: (2012)

Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans
por: Peláez-Ballestas, Ingris, et al.
Publicado: (2016)

Cardiovascular magnetic resonance imaging in rheumatic heart disease
por: NAB, Ntusi
Publicado: (2018)

Molecular Mechanism of Rheumatic Diseases and Efficacy of Current Therapies
por: Umar, Sadiq, et al.
Publicado: (2017)

Opioid use in rheumatic diseases: preventing another pandemic
por: The Lancet Rheumatology
Publicado: (2020)

Rheumatic Diseases: New Progress in Clinical Research and Pathogenesis
por: Koo, Malcolm, et al.
Publicado: (2023)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Panta rhei in diagnosing rheumatic diseases
por: Wiland, Piotr
Publicado: (2019)

Rheumatic and oncological diseases – common challenges
por: Jeziorski, Krzysztof
Publicado: (2017)

COVID-19 – rheumatic diseases and rheumatologists
por: Maślińska, Maria
Publicado: (2021)

Development of a Remote Online Collaborative Medical School Pathology Curriculum with Clinical Correlations, across Several International Sites, through the Covid-19 Pandemic
por: Guiter, Gerardo E., et al.
Publicado: (2021)

Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA(+) individuals without a systemic autoimmune rheumatic disease diagnosis
por: Kim, Sonya T., et al.
Publicado: (2023)

Clinical Impact and Costs of Echocardiographic Screening for Rheumatic Heart Disease
por: Kirkpatrick, James N., et al.
Publicado: (2017)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

Crying out for equity: outcomes of rheumatic diseases confounded by ethnicity
por: Dubey, Shirish, et al.
Publicado: (2022)

Vaccination of patients with autoimmune inflammatory rheumatic disease: physicians’ perspectives
por: Moon, Ki Won
Publicado: (2023)

Exploring the Mental Health Needs of Persons With Autoimmune Diseases During the Coronavirus Disease 2019 Pandemic: A Proposed Framework for Future Research and Clinical Care
por: Bingham, Kathleen S., et al.
Publicado: (2020)

SAPHO syndrome: Is a range of pathogen-associated rheumatic diseases extended?
por: Rozin, Alexander P
Publicado: (2009)

Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases
por: Schulze-Koops, Hendrik
Publicado: (2017)

Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient
por: Mojs, Ewa, et al.
Publicado: (2018)

POOR ADHERENCE TO DRUG TREATMENT IN CHILDREN AND ADOLESCENTS WITH AUTOIMMUNE RHEUMATIC DISEASES
por: Silva, Clovis Artur
Publicado: (2019)

Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
por: Reid, David M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a7bu9dao72rojpbhpkmo6vqsc2